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ABSTRACT
Orthopedic shoulder surgery is a common therapy for many medical conditions,
but the healing process for orthopedic shoulder surgery can be adversely impacted by
chronic shoulder pain. Frequently, chronic pain is not adequately controlled by opioid
analgesics provided to patients during the surgical healing process, resulting in greater
pain and diminished postsurgical mobility. The focus of this Doctor of Nursing Practice
project was to examine the question of whether, among male and female adult patients
(40-64 years of age) with a history of secondary chronic shoulder pain lasting three or
more months who have undergone orthopedic shoulder surgery, the use of an ON-Q pain
pump provided after surgery with hydrocodone as the standard treatment for pain relief,
compared to standard pain relief alone, promoted improved patient post-surgical
outcomes in terms of two- and eight-week postsurgical pain, two- and eight-week range
of shoulder motion, and length of postoperative therapy.
This project used a quantitative methodology and retrospective data review
design, to analyze data previously collected by the organization that served as the project
site. De-identified data provided by the organization to the researcher, of participants who
met specific criteria between January 2017 and October 2018 was reviewed to evaluate
the benefit of utilizing an ON-Q pain pump in conjunction with standard treatment of
hydrocodone for pain relief. The retrospective data analysis used paired-samples t-tests
and mixed-effects tests to compare the intervention and control conditions regarding
postsurgical pain and range of motion outcomes. The project findings failed to indicate
that the use of the ON-Q pain pump offers significant benefits as an adjuvant pain relief
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medication to recommend its consistent use in practice; especially when cost is
considered.
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CHAPTER I – INTRODUCTION
Overview
Between the years 2014-2019, it was projected that more than 19 million
Americans would undergo surgery to treat orthopedic shoulder pain, which encompasses
musculoskeletal and joint pain caused by injuries or physical stressors (Narvy,
Ahluwalia, & Vangsness, 2016). Most orthopedic shoulder surgery patients receive
complete relief of their shoulder pain after recovering from their procedures, but up to
40% of patients continue to experience pain (National Institutes of Health [NIH], 2015).
These ongoing symptoms occur in patients who have two comorbid conditions in the
shoulder targeted for surgery—orthopedic pain and secondary chronic pain. Secondary
chronic pain is pain that lasts three months or more prior to surgery and presents with
locations, characteristics, and/or causes distinct from those of the orthopedic pain (Narvy
et al., 2016). The differences between the two types of pain account for orthopedic
surgery's inability to address chronic pain, despite effectively alleviating the acute pain
that shoulder surgery is utilized to mitigate. Comorbid orthopedic and secondary chronic
shoulder pain tends to adversely impact orthopedic shoulder surgery patients' health
outcomes by increasing postoperative pain and decreasing functional mobility of the
affected shoulder. Ongoing pain and movement limitations impede surgical recovery
processes and can lead to long-term health issues, functional impairments, and poorer
quality of life outcomes (Narvy et al., 2016).
Patients who have both orthopedic and secondary chronic shoulder pain may be
more likely than patients with only orthopedic pain to require readmissions for shoulder
issues, ongoing outpatient pain appointments, and to experience longer recovery times
1

that require additional, and more intensive therapy (Matsen, Tang, Russ, Hsu, & Matsen.,
2017; Shin et al., 2015). A nurse delivering care to orthopedic shoulder surgery patients
who have a secondary diagnosis of chronic shoulder pain can demonstrate core nursing
values and promote high-quality care by using theory-driven, evidence-based strategies
for managing surgical outcomes among patients, including outcomes related to safe and
effective postsurgical pain management.
Background and Significance
American adults commonly experience chronic pain with orthopedic pain,
especially when those forms of pain occur in the shoulder. Annually, chronic pain affects
over 45 million (14.2%) American adults, and 76.5 million (24.6%) Americans
experience severe pain for periods of one day to three months (Fanelli, Cherubino, &
Compagnone, 2014). Orthopedic shoulder pain impacts up to 19 million (5.3%)
Americans each year, while roughly 25 million Americans (7.8%) experience chronic
shoulder pain with causes that are not musculoskeletal, and, therefore, not considered to
be orthopedic in nature (Jain et al., 2014; Narvy et al., 2016). More than 7.5 million
(3.1%) Americans have comorbid orthopedic pain and secondary chronic pain present in
the same shoulder (Narvy et al., 2016).
Pain is a pairing of sensory perception and emotional experience that is
unpleasant or aversive, which generally relates to a stimulus that damages, or could
potentially damage bodily tissue (International Association for the Study of Pain [IASP],
2017). Orthopedic shoulder pain and chronic shoulder pain comprise separate diagnoses,
due to significant distinctions between the two conditions. Orthopedic pain originates in
striated muscle, bone, or joints, and tends to be caused by repetitive stress or traumatic
2

injury. Orthopedic shoulder pain may occur following fall injuries or repetitive arm
motions (Evanoff et al., 2014). One of the most common causes involves tears of the
rotator cuff, with a surgical incidence rate of 250,000 Americans per year. The second
most common cause, as a group, are fractures of the proximal humerus, which have an
overall incidence rate of 184,000 adults per year in the United States, although surgeries
are performed in only 36,800 cases (Jain et al., 2014).
Chronic pain definitions vary, but many clinicians, researchers, clinical
guidelines, and healthcare organizations define chronic pain as pain that lasts most of the
day or all day and is experienced on a nearly consistent or consistent basis for at least
three months (National Institutes of Health [NIH], 2010). Chronic shoulder pain may
have a variety of causes, which may occur without physical injury, such as pain caused
by inflammatory autoimmune diseases, or may even emerge from dysfunctional nervous
system activities, without any apparent cause (NIH, 2010). In some cases, chronic
shoulder pain may involve musculoskeletal pain that emerges as a complication from the
initial orthopedic shoulder pain but involves distinct injury processes and presents in a
different part of the shoulder. The differences that orthopedic shoulder pain and chronic
shoulder pain have in their locations, causes, and pain characteristics prevent orthopedic
shoulder surgeries from alleviating chronic shoulder pain.
The societal costs of pain are enormous, creating annual healthcare expenses
estimated to range from $560-$635 billion in the United States alone (IASP, 2017). Pain
also creates additional indirect costs through work missed due to pain or medical care,
reduced productivity, early retirement, and premature death (IASP, 2017; Shin &
Regenstein, 2016). Chronic pain and orthopedic pain are particularly problematic in
3

terms of creating indirect costs because they can limit functionality to the point that
certain jobs and tasks become impossible to perform. Comorbid orthopedic and chronic
shoulder pain is more likely than orthopedic shoulder pain alone to engender functional
limitations, individual costs, and indirect societal costs by reducing the likelihood of
success for orthopedic surgeries (Shin et al., 2015). Compared to orthopedic shoulder
surgery patients who do not have a comorbid chronic shoulder pain diagnosis in the same
shoulder, patients who have ipsilateral chronic shoulder pain comorbid with orthopedic
shoulder pain show postsurgical recovery costs that are 50% higher and require up to four
additional weeks of postoperative physical and occupational therapy (Fanelli et al., 2014).
This project was significant for several groups of stakeholders. First, and most
importantly, the project held significance for orthopedic shoulder surgery patients
diagnosed with comorbid orthopedic shoulder pain and chronic shoulder pain in the same
shoulder by providing evidence useful in improving these patients' postoperative health
outcomes and quality of life. These improvements would be realized by several project
effects, including possible improvement of postoperative pain, increased range of motion
for the affected shoulder; and participation in rehabilitative therapies. These outcomes
could reduce the need for follow-up surgeries and additional opioid prescriptions to
manage shoulder pain (Matsen et al., 2017; Srikumaran, Stein, Tan, Freehill, & Wilckens,
2013). For nurses, physicians, physician assistants, sports therapists,
occupational/physical therapists, and home care providers who are specialized in the field
of orthopedics or postsurgical rehabilitation, the project findings could be useful in
developing new guidelines for treating, benchmarking, and monitoring the recovery of
patients who have had orthopedic shoulder surgeries and also have a secondary diagnosis
4

of chronic pain not addressed by the surgery. Organizations such as the IASP and NIH
may consider incorporating positive findings into their recommendations for orthopedic
shoulder surgery recovery. Nurse researchers, orthopedic centers, medical equipment
developers, pharmaceutical firms, and public health care providers may also consider
using the findings as a starting point for developing more effective pain pumps. These
considerations should be addressed in order to provide the most effective pain
management for patients who experience both chronic and orthopedic shoulder pain.
Review of the Evidence
The current literature was reviewed to determine whether there was adequate
information to recommend the use of further studies to examine the merits of pain pumps
such as the ON-Q pump that this study focused on. The literature search provided a basis
for this study through demonstration that sufficient evidence already exists to explore the
use of the ON-Q pump as an adjuvant therapy, in addition, to traditional oral opioids
following orthopedic shoulder surgery in patients with secondary chronic pain in the
shoulder area. The literature review also highlighted that there were gaps in the current
evidence that would make such a study valuable and capable of contributing to the
current knowledge on this topic. These concepts formed the basis for the review of
evidence that is discussed in the subsections found below.
In order to conduct the review of the evidence, a search of the available literature
was undertaken. The methodology of the literature search was as follows. The primary
researcher used multiple online databases that could return full-text, peer-reviewed
results from scholarly articles in academic and professional journals. The databases that
were examined in this literature search included Academic Search Complete by EBSCO,
5

Google Scholar, MEDLINE, CINAHL Plus, the Cochrane Database of Systemic
Reviews, and the Cochrane Central Register of Controlled Trials. These databases were
searched with a focus on articles published in the last five years, with a few exceptions
that were made for seminal theoretical or research publications, such as the cornerstone
work by Watson (1979) that was applied as part of the theoretical basis for this study.
The search terms that were employed included “orthopedic shoulder surgery,” “shoulder
surgery,” “pain pump,” “orthopedic surgery,” “ON-Q,” “ON-Q pump,” “adjuvant
therapy,” “adjuvant pain therapy,” “postsurgical therapy,” “postoperative therapy,”
“chronic pain,” “secondary chronic pain,” “musculoskeletal pain,” and combinations of
these search terms. Out of the several hundred results that were obtained from the search,
the full-text, peer-reviewed options were checked, and the search results were limited to
those after 2012, except in a few select cases as mentioned above, which allowed for the
researcher to obtain roughly 50 articles. These articles' abstracts were perused carefully to
ensure they would be applicable to the study, and those articles that met the criteria were
selected for inclusion in the review of the literature. The primary researcher read the full
texts of these relevant articles. The Literature/Evidence Matrix (see Appendix A)
includes basic information on these extant pieces of literature, including (a) author, year,
and title; (b) level and grade; (c) experimental design; (d) sample size, constitution, and
data collection methods; (e) research findings; (f) potential limitations; and (g)
recommendations.
This literature search was divided into conceptual elements, including the
epidemiological and economic need for improving upon the conventional method of
solely using traditional oral opioid analgesics as a postoperative pain control remedy for
6

orthopedic shoulder surgery in patients with secondary chronic shoulder pain, followed
by examining the utility and feasibility of peripheral nerve block medication such as
Marcaine, along with a pain pump delivery system, with a particular focus on the usage
of these medications and delivery systems in orthopedic shoulder surgery patients.
Correspondingly, the information yielded from the review of the evidence is also
arranged by topic.
Epidemiological Issues and Economic Impact
The basic information on the orthopedic shoulder surgery patients who also face
secondary chronic shoulder pain was one prominent theme that emerged from the
literature. This theme was important because it provided a basis for conducting this study
and showed the extent to which improvements upon the current state of orthopedic
postoperative treatment could potentially help large numbers of patients in the United
States. Clarke, Nahin, Barnes, and Strussman (2016) conducted a nationwide survey of
34,525 American adults that involved a combination of questionnaires and reviews of
health records, musculoskeletal pain was an extremely frequent phenomenon among the
respondents. Just over half of all the people interviewed, 54.5%, had self-reported some
type of chronic musculoskeletal pain (Clarke et al., 2016). In the research conducted by
Clarke et al. (2016), it is important to note that not all reports of pain were specific to the
shoulder, but shoulder pain was one of the most frequently reported sources of chronic
pain in other studies.
Other research studies demonstrated that orthopedic shoulder surgeries are both a
common and costly phenomenon in the United States. Narvy et al. (2016) had estimated
that each orthopedic shoulder surgery had a cost of around $5,904, but repeated surgeries
7

tended to become more expensive due to complications. One descriptive epidemiological
study that had been conducted by Jain et al. (2014) reviewed records that totaled 34.7
million hospital visits by Americans during the year of 2006. In that annual period, Jain
et al. (2014) estimated that there had been more than a half million orthopedic shoulder
surgeries performed. Their analysis showed 272,148 rotator cuff surgeries and 257,541
shoulder arthroscopy surgeries not involving the rotator cuff, with 55-74-year-old
patients comprising the largest group who required rotator cuff surgeries (Jain et al.,
2014). The analytical data reported by Jain et al. (2014) is broadly consistent with the 1%
shoulder pain diagnosis prevalence reported by Tekavec et al. (2012). Likewise, Narvy et
al. (2016) found the mean age of patients requiring shoulder surgery to be 54.5 years of
age. Several conditions, such as impingement syndrome, bursitis, periarthritis, and
instability, some of which can result from a failure to fully recover from past surgeries,
tended to be the main reasons that rotator cuff surgeries were needed (Jain et al., 2014).
Kim, Szabo, and Marder (2012) conducted an epidemiological study that involved a
review of retrospective medical histories from 28 million emergency department records
during the year of 2008. During that time frame, some 370,000 visits were due to humeral
fractures, which can, but do not always, require some form of orthopedic intervention for
treatment (Kim et al., 2012). The age groups who were at the greatest risk for these
injuries included women between the ages of 40 and 80 years old (R²=97.9%) and men
who were between 60 and 89 years of age (R² = 98.2%) (Kim et al., 2012). As the current
workforce ages, researchers have predicted that the number of humeral fractures could
surpass 490,000 by the year 2030, with the highest incidence predicted in workers who
perform intense physical labor (Kim et al., 2012).
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In several studies involving body mass index (BMI) as a predictor of orthopedic
shoulder pain issues, as well as those involving employees of fields that demanded
intense or frequent physical labor, shoulder pain had emerged as the main basis of painrelated complaints among respondents. Vincent, Struk, Reed, and Wright (2016) found
obesity to be linked to a higher rate of shoulder problems and poorer recovery from
orthopedic surgery. In a cohort study that had been conducted by Evanoff et al. (2014),
9,145 retired male individuals, ages 63-72 years old, were assessed in terms of their BMI
and their level of physical activity prior to retirement, including whether their jobs had
involved more than 10 years of frequent arm elevation or squatting. Evanoff and
colleagues (2014) found that those individuals who were obese were more likely to
experience shoulder pain later in life, as were individuals who had either engaged in more
than 10 years of frequent arm elevation or squatting. Similarly, a study by Kim, Dutra,
and Okechukwa (2014a) assessed 1,772 construction apprentices regarding work site
safety practices and the number of days absent from the job due to injury. The research
determined that there was a significant odds ratio (OR 1.68) linking an absence of
personal and coworker safety practices to the likelihood of suffering an injury-related
absence from work. Many of the work absences documented in the study involved
chronic pain issues and injuries requiring orthopedic surgical remedies (Kim et al.,
2014a). These associations are not limited to construction workers and laborers as other
research has noted similar problematic associations among other professionals.
The field of nursing was also found to show correspondences between higher
levels of physical activity and orthopedic pain (Kim et al., 2014b). Kim et al. (2014b)
performed a cross-sectional study that interviewed 1,572 nurses from two teaching
9

hospitals in the United States, and asked questions regarding staffing levels at the
workplace and determined musculoskeletal pain via the Nordic questionnaire. The
logistic regression model that the researchers used to analyze the data found that there
were significant associations between reported low staffing levels (OR 1.5) and higher
numbers of areas on the body that the participants reported experiencing chronic pain
(OR 1.42). The positive association was still present when other factors were controlled
for such as the number of hours that the participants worked per week, whether the
participants had a second job, and their job roles. Shoulder pain remained significantly
associated with understaffing even after the physical task demands of the nurses' jobs had
been controlled within the logistic regression analysis (Kim et al., 2014b). These results,
along with those of Kim et al. (2014a) and Evanoff et al. (2014) indicate that, as
individuals in high-employment, high-growth fields like labor and nursing get older, they
may have a greater need for therapies that involve orthopedic surgery and secondary
chronic pain control.
Adjuvant Medications for Pain Control
The use of adjunct medications for pain control often begins with the patients
themselves. In the nationwide survey by Clarke et al. (2016), individuals with
musculoskeletal pain (41.6%) were significantly more likely to have used adjuvant or
alternative therapies compared to those without such pain (24.1%). However, many of
these therapies could be considered truly “alternative” in that they were simply
applications of natural products (24.7%) rather than practitioner-guided approaches
(18.2%) or strategies that involved multiple components of the medical system (5.3%)
(Clarke et al., 2016). This information suggested that individuals with chronic pain may
10

have received inadequate pain control. A survey conducted by Fanelli and colleagues
(2014) that surveyed 143 orthopedic specialists provided some insight into the
undertreatment of pain phenomenon. The work by Fanelli et al., (2014) reported that of
the 143 orthopedic specialists that were surveyed, 70% had a high degree of knowledge
regarding the use of opioid and medical adjuvant therapies such as nerve blocks,
including Marcaine. However, less than half (45.5%) of the specialists had prescribed
these medical therapies on a regular basis following orthopedic procedures. Reasons cited
for the orthopedic specialists’ reluctance to prescribe were side effects/adverse reactions
(45%) and patient resistance to opioid therapy (29%) (Fanelli et al., 2014).
The results of these studies indicated a few issues with postoperative therapy
following orthopedic shoulder surgery. First, the patient may not have received adequate
levels of pain relief following surgery due to a combination of practitioner unwillingness
to prescribe high levels, or in some cases any levels, of opioids (Fanelli et al., 2014).
Patients and even practitioners themselves may be unaware that there are other options
for pain relief aside from higher doses of opioids, which may not be completely effective
in cases of chronic pain. This finding suggests there is a need for health care provider
training and patient education regarding the use of options such as pain pumps following
orthopedic shoulder surgery.
The information regarding adjuvant therapies for postsurgical therapy that have
been researched in the literature already showed that these therapies have promise for
assisting in orthopedic surgical cases, although at the same time, there have been
surprisingly few studies that focused solely on issues of orthopedic shoulder surgery in
patients who have also been diagnosed with secondary cases of acute shoulder pain.
11

Hamandi, Al-Khafaji, and Al-Atbee (2013) conducted a small case study comparison that
involved the use of opioid and adjuvant therapies as treatments for orthopedic surgeries
and chronic pain. They found that the combination of both medications using a pain
pump helped to reduce patient-reported pain as well as objectively measured spasticity
after surgery. However, it is important to note that the sample was not only small but
involved delivering both opioid and non-opioid medications through pain pumps, which
is a therapeutic strategy not generally used in American medicine. Moreover, their study
was not solely limited to orthopedic shoulder surgeries. They noted the need to measure
not only pain but muscle movement. Matsen et al. (2017) described a study of 104
persons with osteoarthritis whose ranges of movement were measured prior to surgery.
The participants' ranges of movement for active abduction and several different shoulder
activities were recorded for both the arthritic and the contralateral shoulder prior to
surgery. Matsen and colleagues’ (2017) study determined that subjective measures of
shoulder movement conducted by the patients tended to show significantly less activity
and poorer ranges of motion than the objective measures. These outcomes demonstrated
the importance of promoting pain control, which also resulted in objective improvements
in movement as a product of therapy postoperatively.
The ability of adjuvant nerve blockers and pain inhibitors to aid in pain control
after orthopedic surgery has been analyzed in several studies. Patacsil (2016) conducted a
systemic review of randomized controlled trials and meta-analyses and determined that
nerve blockers tend to be more effective for upper-extremity surgeries, including those
involving the shoulders, compared to lower-extremity surgeries. Patacsil stated that these
therapies could be advantageous not only for reducing pain but because they could reduce
12

the number of opioids patients would require after surgery, simultaneously decreasing the
risks of opioid-related side effects. Shin et al. (2015) studied arthroscopic anterior
shoulder stabilization outcomes and determined that instability occurred in about 19% of
patients, most of whom had previous complications from prior shoulder surgeries, and
that hyperlaxity was another issue that pre-empted postoperative complications. Both
issues, however, could potentially be addressed through peripheral nerve blocks,
according to both Patacsil (2016) and Srikumaran et al. (2013), who examined the
utilization of peripheral nerve blocks on postsurgical outcomes, and determined that these
nerve blocks not only reduced pain but were effective in improving range of motion and
recovery times for patients.
Synthesis of Evidence
The review of evidence supported this Doctor of Nursing Practice (DNP) project
in several ways. The need to examine adjuvant pain relief methods in order to avoid
increasing doses of opioids after surgery and to address chronic shoulder pain that often
has a neurological basis that is not adequately controlled by opioids has been reported
(Clarke et al., 2016; Fanelli et al., 2014). Nerve blockers have been found to be effective
in reducing pain and promoting increased range of motion, although only a limited
amount of research has focused specifically on shoulder surgery patients regarding these
outcomes (Patacsil, 2016; Srikumaran et al., 2013). However, ample evidence exists to
support using both a subjective measure like patient pain ratings per a Likert scale and
objective provider-measured range of motion assessments to evaluate the effectiveness of
adjuvant pain control methods in promoting improved patient outcomes after surgery
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(Hamandi et al., 2013; Matsen et al., 2017). These issues factored into the need for this
DNP project.
Needs Assessment
Pain pumps such as ON-Q and similar pieces of equipment have been studied for
the past decade, but many of the studies that have been performed have not had
methodologies or findings that are generalizable to orthopedic shoulder surgery patients
with chronic pain. Many of the studies that have been performed on pain pumps and the
use of anesthetics have focused on which medications, or combination of medications,
are capable of delivering the longest lasting pain control in a limited area of the body, and
how small or large of an area of tissue can be effectively provided with pain relief during
a given time (Patacsil, 2016). Yet these pain studies have rarely examined range of
movement, an acknowledged critical function for recovery of one's functionality in daily
life and mobility (Matsen et al., 2017).
Several studies that have specifically focused on orthopedic shoulder surgery
recovery outcomes and the use of anesthetics have extrapolated data from prior studies
that referenced outcomes on knee or shoulder surgeries. Other studies have considered
pain pumps for not only shoulder surgeries in the sample, but also surgeries affecting the
arms or other areas of the upper body (Shin et al., 2015; Vincent, Struk, Reed, & Wright,
2016). Still, other shoulder surgery studies involving anesthetics have either examined
inpatient or outpatient nerve blocks for shoulder surgery, which use similar medications,
but not the same patient-operated delivery systems, as pain pumps (Srikumaran et al.,
2013). Controlled trials comparing pain pump anesthetics along with oral opioids versus
control of oral opioid medication for postsurgical patients, as opposed to comparing
14

different pain pumps, are also somewhat rare (Hamandi et al., 2013). Therefore, there is a
pressing need for patients, practitioners, and other stakeholders in orthopedic care to
examine whether pain pumps can be applied as an adjuvant therapy to the standard oral
opioid therapies generally prescribed and for such a study to involve a control group.
The findings of this DNP project could impact the current and future health of the
United States. Right now, hundreds of thousands of orthopedic surgery patients
experience secondary chronic pain that is generally not adequately treated by the present
methods and guidelines used to rehabilitate them, creating a need for practice and
guideline changes (Tekavec et al., 2012; U.S. Census Bureau, 2017). Longer surgery
recovery times create higher Medicaid and Medicare costs, along with higher private
insurance costs, because many patients exceed eight weeks for recovery and require
additional outpatient care, or inpatient readmissions due to surgical complications such as
manual shoulder manipulation under anesthesia (MUA) and revision shoulder surgeries
(Jain et al., 2014). Americans who work in professions with strenuous job duties such as
contractors and construction workers, as well as workers with increased demand and
problematic staffing levels, like hospital staff and nurses, are more likely to experience
shoulder injuries requiring surgery (Kim et al., 2014a; 2014b). Shoulder injuries and
chronic pain often arise between the ages of 40 and 64; as the Baby Boomer Population
continues to age, this demographic continues to increase exponentially (Howden &
Meyer, 2011). The growing rate of obesity in the nation, which can also cause physical
strain resulting in chronic pain and shoulder injuries that require surgery, will likely mean
that there will be a corresponding increase need for orthopedic shoulder surgeries among
patients with secondary chronic shoulder pain (Evanoff et al., 2014; Vincent, Struk,
15

Reed, & Wright, 2016). This project's findings could possibly assist future generations of
patients, health care providers, taxpayers, and employers as it sought to analyze deidentified data provided to the researcher from a study conducted solely by the project
organization.
Problem Statement
The scope of this DNP project was to analyze pre-prepared organizational data to
determine whether there were novel approaches to pain relief that may alleviate the pain
experienced by patients with a dual diagnosis of both chronic and acute orthopedic
shoulder pain. Decreasing postsurgical pain has been noted to decrease postoperative
complications, decrease costs associated with prolonged recovery time, and increase the
quality of life (Matsen et al, 2017; Srikumaran et al., 2013). The adjuvant pain control
therapy that was evaluated against the standard of care for this project was an ON-Q pain
pump. The ON-Q pain pump is a patient-operated device implanted via a temporary,
clinically monitored catheter. The ON-Q pain pump delivers a pre-set flow of local
anesthetic that may be increased by the patient in 2 mL increments to a maximum flow of
10 mL/per hour. The de-identified data provided to the project leader included patients
who did and did not receive placement of an ON-Q pain pump. For the patients who did
receive the adjuvant therapy a CB004 550 mL pain pump was inserted by the provider
via catheter with a combination of 0.125% Marcaine 400 mL, and ketorolac 150 mL,
with a baseline rate that depended on the patient's size and condition; however, all
patients had the ability to increase the flow by 2 mL, with a limit of 10 mL per hour (see
Appendix B). All patients who had placement of the ON-Q pain pump were provided
appropriate education concerning proper care including flow adjustment practices and
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how to identify when the pump was empty. The ON-Q pump's ball is identified as empty
when the patient feels and sees a hard-yellow core and may then remove the ON-Q
device and catheter at home which lasts approximately four to five days depending on the
flow rate (Clarke et al., 2016).
For this DNP project, de-identified organizational data was retrospectively
reviewed on patients who underwent shoulder surgery at the project site between January
2017 and October 2018. According to the organizational guidelines, participants were
grouped according to pre-determined criteria. Dependent on insurance coverage, patients
were provided an ON-Q pain pump after surgery as an adjuvant therapy alongside
standard medications for postsurgical pain relief. As mentioned above, opioids such as
hydrocodone 7.5-10 mg are given as a standard postsurgical medication. These
medications are generally quite effective at treating the type of acute pain that patients
often experience for several weeks following orthopedic shoulder surgery. When opioid
analgesics are utilized for postoperative pain, in recommended doses they are generally
considered safe and effective. However, development of dosage tolerance, as well as
physical and mental dependence can occur when they are not taken as directed or are
utilized for an extended period (Fanelli et al., 2014). Additionally, chronic pain may not
be caused by internal or external stimuli that is directly contributing to tissue damage,
and, therefore, may not be adequately controlled by safe, therapeutic doses of opioids that
are sufficient for addressing chronic shoulder pain (Fanelli et al., 2014).
In order to provide adequate pain control for chronic pain it is recommended to
provide medications or other methods that block the nociception, or pain, signals from
originating from the nociceptor nerves responsible for detecting and conveying pain
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signals in different areas of the body (Patacsil, 2016). The medications that are provided
within pain pumps such as the ON-Q pump are regional or local anesthetics that provide
long-term pain relief by eliminating the initiation and transmission of electrochemical
signals from nociceptors, thereby preventing the individual from experiencing the chronic
pain while the patient undergoes their rehabilitative activities and activities of daily
living.
Project Purpose
This DNP project was guided by a retrospective data analysis of a single
Population, Intervention, Control, Outcome, and Time (PICOT) question, “Among male
and female patients, ages 40-64 years, who are living with secondary chronic shoulder
pain lasting more than three months, and who have undergone orthopedic shoulder
surgery (P), would the use of an ON-Q pain pump in addition to standard treatment for
pain relief involving the use of 7.5-10 mg hydrocodone (I) compared to receiving the
standard treatment for pain relief alone (C) improve patients' postsurgical outcomes by
increasing range of motion in degrees at 2 and 8 weeks postoperatively, promoting a pain
score of less than 5 on a 10 point Likert scale, and decreasing the length of postoperative
therapy from 12 to 8 weeks (O) over the course of 8 weeks (T)?” This PICOT question
was developed through examining the current literature on the topics of orthopedic
shoulder surgery, shoulder surgery rehabilitation, and chronic shoulder pain. Although
opioid analgesics are the general method of pain relief that is used for postsurgical pain,
short-acting opioids are more effective solely for the acute pain of surgical recovery and
may fail to impact the chronic pain that stems from different physical sources (Patacsil,
2016; Srikumaran et al., 2013).
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Theoretical and Conceptual Framework
The theoretical and conceptual framework that was utilized for this project was
Jean Watson's Theory of Human Caring. According to Watson (1979), this grand theory
accounts for patients' health as going beyond being “disease-free” to encompass a
situation where a patient's holistic needs, including biophysical needs, but also
psychophysical and psychosocial needs are being simultaneously met. Exposure to
stressors may prevent needs from being met or may decrease a patient’s senses of
empowerment and value. Empowerment and value of self are vital for the patient’s selfcare behaviors and recovery. To effectively treat patients, the nurse delivers evidencebased interventions, or curing, along with charitable actions, teaching moments,
transpersonal contact, mutually respectful and trusting relations, and caring moments
with their patients (Watson, 2009). This DNP project applied Watson’s theory by
conceptualizing surgical recovery as a process where patients required care to manage
multiple biophysical needs, like chronic pain and surgical recovery pain. The goal was to
retrospectively analyze data to determine if the patient achieved optimal psychophysical
and psychosocial outcomes by acquiring functional independence and mobility. Teaching
moments, mutual trust, evidence-based practices, and caring/compassionate moments are
all necessary from the organizational staff to successfully deliver this information to
patients.
Evaluation Plan
This DNP project retrospectively reviewed, previously collected, de-identified
data. The outcomes of interest for the project included (a) patients' self-reported pain
scores at two and eight weeks after surgery, (b) two-week and eight-week ranges of
19

motion for the shoulder affected by surgery, and (c) the number of weeks patients needed
for physical therapy after surgery. This data was routinely recorded during postsurgical
follow-up appointments at the project site by the organizational clinical staff and treating
physician. The orthopedic clinic staff routinely conducted and record the pain and range
of motion assessments in patient’s charts when participants presented for their two-week
and eight-week follow-up evaluations. During these visits, the clinic staff also identified
the physical therapy needs of the patients in their progress and therapy notes, including
whether the patients no longer needed occupational/physical therapy. The outcomes of
interest were then collected through a retrospective chart review that did not include the
names or other forms of personally identifiable information about the participants. The
only health information collected and provided to the project leader included the
variables of interest and the information on participant group, as denoted by the presence
or absence of an ON-Q request form, shown in Appendix B. The PICOT question was
evaluated by taking the mean values of the two week and eight-week pain scores, two
week and eight-week ranges of motion in degrees, and weeks required for physical
therapy for the intervention and control groups. Between group, t-tests were conducted to
compare the group mean values for these variables to determine whether the ON-Q pain
pump with oral hydrocodone was associated with better postsurgical outcomes when
compared to the standard care condition with only oral hydrocodone.
DNP Essentials
The DNP essential elements of the American Association of Colleges of Nursing
(2006) were considered and utilized for this project. Essential I: Scientific Underpinnings
for Practice was me by conducting a literature review, formulation of a hypothesis from
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noted gaps in available literature and performing a retrospective data analysis. Essential
II: Organizational and Systems Leadership for Quality Improvement and Systems
Thinking, was met through determining whether a novel postsurgical treatment method
could reduce rehabilitation times, thereby improving health system functionality.
Essential III: Clinical Scholarship and Analytical Methods for Evidence-Based Practice
was met with the analysis and synthesis of the current literature, and the quantitative
collection and analysis of data. Essential IV: Information Systems/Technology and
Patient Care Technology for the Improvement and Transformation of Health Care, was
met using the ON-Q pump, a novel therapy for adjuvant pain control, utilization of
databases to search for literature, and utilization of the facility's records to obtain needed
data. Essential V: Health Care Policy for Advocacy in Health Care could be derived from
the results, which might help influence future guidelines in postsurgical treatment.
Essential VI: Interprofessional Collaboration for Improving Patient and Population
Health Outcomes was met by working with interdisciplinary teams to discuss project
findings as it related to the use of novel approaches of the ON-Q pumps Essential VII:
Clinical Prevention and Population Health for Improving the Nation’s Health, was
achieved through analysis of the data which could aid in preventing complications and
readmissions related to poor patient recovery from surgery. Essential VIII: Advanced
Nursing Practice was met through the role of an advanced practice nurse functioning as
the project leader and conducting the project’s data analysis to answer an important
clinical question.
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Summary
Orthopedic shoulder surgery is a common method for addressing shoulder
conditions, but comorbid secondary chronic shoulder pain can impede surgical healing
and worsen health outcomes, making safe, effective pain relief an important element of
facilitating shoulder surgery patients’ health and well-being. This DNP study investigated
the PICOT question, “Among male and female patients, ages 40-64 years, who are living
with secondary chronic shoulder pain lasting more than 3 months, and who have
undergone orthopedic shoulder surgery (P), will the use of an ON-Q pain pump in
addition to standard treatment for pain relief involving the use of 7.5-10 mg hydrocodone
(I) compared to receiving the standard treatment for pain relief alone (C) improve
patients' postsurgical outcomes by increasing range of motion in degrees at 2 and 8 weeks
postoperatively, promote a pain score of less than 5 on a 10 point Likert scale, and
decrease the length of postoperative occupational/physical therapy from 12 to 8 weeks
(O) over the course of 8 weeks (T)?”
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CHAPTER II – METHODS
Overview
This chapter describes the methods utilized for this DNP project. The chapter
discusses the setting for the project, a private orthopedic practice clinic. This chapter then
describes the target population that the project sought to investigate and contextual
elements of the project. Subsequently, the chapter provides an overview of the research
design and describes ethical considerations. The final section summarizes the contents of
the chapter.
Setting
This DNP project was conducted in a private orthopedic practice specialty clinic
located in an urban metropolitan area located in Coastal Mississippi. This clinic provides
outpatient surgical procedures including reverse total shoulder arthroplasty (RTSA) and
arthroscopic rotator cuff tear repair (RCTR). Between January 2017 and October 2018,
the clinic provided a combined total of 156 reverse total shoulder arthroplasty procedures
and arthroscopic rotator cuff tear repair procedures. The clinic also provides follow-up
care to surgical patients in the form of outpatient appointments at two and eight weeks
after surgery.
Target Population
The target population for this DNP project consisted of 56 male and 44 female
patients, ages 40-64 years old, who received either a RTSA or arthroscopic RCTR
procedures at the project setting between January 2017 and October 2018. While there
were 156 patients total who received these procedures within the aforementioned time
frame; there were only 100 individuals who were inside of the 40-64-year age range
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inclusion criteria. Therefore, this project's target population was comprised of 100
individuals who met criteria for data review and analysis.
Contextual Elements
The contextual elements for this DNP project related to the project leader's
qualifications as a registered nurse preparing for the DNP degree, who is also currently
working in perioperative care at the clinic that served as the DNP project site. The project
leader conducted a retrospective chart review of de-identified organizational data of
patients that underwent orthopedic shoulder surgery at the project site location during the
organization’s predetermined time span. This project leader has knowledge of the
practices required for safe and effective care for the intervention and control conditions,
as aforementioned and outlined by the organizational study as well as an understanding
of patient needs, and evidence-based practice required for delivery of high-quality care.
Most importantly, the project leader was dedicated to the confidentiality and privacy of
the patients whose charts were retrospectively reviewed for data analysis. To ensure
patient confidentiality and privacy, aggregate patient data from datasets with all
personally identifying information on the participating patients were removed prior to the
project leader receiving the information.
Design
This DNP project used a retrospective evaluation design to evaluate and analyze
the role of the ON-Q pain pump as adjuvant therapy for promoting improved outcomes
among patients receiving orthopedic shoulder surgery who also had secondary chronic
shoulder pain. The project leader was provided with de-identified data, previously
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collected by the organization. The de-identified data that was reviewed for this project
included information on patients who underwent either reverse total shoulder arthroplasty
or arthroscopic rotator cuff tear repair procedures between January 2017 and October
2018 at the project site. The patients were identified during this period by the
organization as eligible to receive an ON-Q pain pump, as permitted by their insurance
coverage, and received either standard pain relief or the intervention conditions of
standard pain relief plus the ON-Q pain pump according to pre-surgical assessments that
involved their diagnosis, age, surgical procedure code, and insurance coverage. The
patients received information about the ON-Q pain pump if they were eligible for
participation, according to insurance coverage, and consented for surgical intervention
including the use of the adjuvant therapy per the organizational guidelines.
The demographic information was collected during the patient’s initial evaluation
and consultation for surgery, according to the organization’s usual standard of practice.
The de-identified data was then reviewed retrospectively by the project leader. The
employee who collected and maintained the data was a registered nurse who was an
employee of the project setting and certified in HIPPA compliance. This registered nurse
ensured collection of variables of interest on surgical consult patients and entered the
variables into the patient’s electronic medical record. Variables of interest recorded
during the consultation included: (a) the type of surgical procedure the participant
received, (b) the comorbidity of secondary chronic pain, (c) the date of secondary pain
diagnosis, and (d) the control or intervention group assignment. This data was
subsequently provided to the researcher for retrospective review and analysis.

25

The patients underwent their scheduled outpatient surgeries and received either
the intervention or control pain relief regimen as designated per insurance coverage. At
the follow-up appointments occurring at two and at eight weeks postsurgical procedure,
the aforementioned registered nurse recorded the following variables in the patient’s
electronic medical record: (a) the patient’s self-reported numeric pain level scores, (b)
range of motion in degrees, and (c) usage of occupational/physical therapy services. The
passive range of motion was recorded at two weeks, and the active range of motion was
recorded at eight weeks. The registered nurse also recorded the variables of interest in a
spreadsheet, according to their customary job duties. Variables were linked to randomly
assigned numbers. The randomized number association ensured that the patient’s identity
was shielded from this researcher during data extraction, review, and analysis.
The data analysis approach for the project was quantitative and utilized the
statistical software SPSS version 25. All data points that corresponded with the collected
variables of interest from participants mentioned previously were entered in the SPSS
software. The data set permitted aggregate analysis while avoiding the inclusion of
personally identifying information on any participants. Using the data set, descriptive
statistics were conducted for the sample and each sample group, namely, the intervention
and control groups, for both demographic and study variables. A two-tail t-test was then
used to compare the mean two week and eight-week values for each sample group's pain
scores and range of motion in degrees. Between-group t-tests were used to compare the
control and intervention sample groups in terms of their mean two-week pain scores,
mean eight-week pain scores, mean two-week range of motion, mean eight-week range of
motion, and mean weeks required to complete physical therapy. A two-tailed t-test was
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used and a p-value of p<0.05 to determined significance. The between-group t-test was
chosen as a method to allow a hypothesis to be tested that considers whether there are
differences between two different sample group means (Delorme, 2005). Mixed-effect
tests were also used to assess the possibility of differences between marginal means for
the pain and range of motion variables at the two- and eight-week time points, and a pvalue of p<0.05 to determined significance.
Ethical Considerations
The ethical considerations in the project involve the need to protect the
participants' identities even in the context of a retrospective evaluation. Electronic data
related to the project was stored in a password protected file located on clinic devices
requiring password-protected logins with unique login identification, while all physical
data was locked in file drawers. Participants' confidential health information was only
accessed for data entry purposes into files that contained no identifying information.
Provisions for data security and protection of physical and electronic data as applicable to
state and federal regulations were followed. The data was reported in aggregate form
without any identifiers regarding the identity of participants or the site of the research.
Summary
This chapter presented the methodology for this DNP project. The setting was a
private practice orthopedic specialty clinic in an urban location of Coastal Mississippi.
The target population was comprised of 40-64-year-old adults, male and female,
receiving reverse total shoulder arthroplasty or arthroscopic rotator cuff tear repair
procedures between January 2017 and October 2018. The contextual elements related to
the project leader's experience in providing perioperative care to the patients whose data
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was used in the study. The study was a retrospective evaluation of two- and eight-week
chart data during follow-up appointments after shoulder surgery for participants. The
ethical considerations involved the use of measures to protect the safety, confidentiality,
and privacy of patients whose de-identified data were retrospectively reviewed for project
purposes.
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CHAPTER III – RESULTS
Overview
This chapter presents the findings from the project. The main section in the
chapter briefly outlines the descriptive statistics for the project and then presents the
results of the inferential statistics. This chapter concludes with a summary of the project
findings.
Project Results
The descriptive statistics for this project showed that, out of 100 patients included
in the analysis, 44 were female, and 56 were male, while 36 received the ON-Q pain
pump as an adjuvant therapy with oral hydrocodone, and 64 received oral hydrocodoneonly. Table 1, below, shows the mean values of the ranges of motion for passive forward
flexion (PFF), active forward flexion (AFF), passive abduction (P ABD), and active
abduction (A ABD), as well as self-reported pain scores at two and eight weeks for the
sample as a whole.
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Table 1
Outcome Mean Scores by Time Point and Sample
Paired Samples Statistics

Pair 1

Mean

N

Std. Deviation

Std. Error Mean

ROM 2WK PFF

102.90

100

11.746

1.175

ROM8 WK AFF

159.60

100

21.245

2.125

91.95

100

9.263

.926

149.90

100

27.934

2.793

PAIN 2 WK

4.02

100

2.674

.267

PAIN 8 WK

3.51

100

2.725

.272

Pair 2 ROM 2WK P ABD
ROM 8WK A
ABD
Pair 3

The first inferential statistical analysis that was conducted, shown in Table 2,
involved paired-samples t-tests for the mean range of motion in degrees and mean selfreported pain scores at the two- and eight-week time points, for the entire sample. The
sample showed significantly (p=0.000) larger mean ranges of motion in degrees at eight
weeks compared to two weeks for both measures. However, the sample did not show a
significantly (p<0.05) smaller mean self-reported pain score at eight weeks compared to
two weeks.
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Table 2
Paired-Sample t-test Results for Sample
Paired Samples Statistics

Pair 1

Pair 2

Pair 3

Mean

N

Std. Deviation

Std. Error

ROM 2WK PFF

102.90

100

11.746

1.175

ROM8 WK AFF

159.60

100

21.245

2.125

ROM 2WK P ABD

91.95

100

9.263

.926

ROM 8WK A ABD

149.90

100

27.934

2.793

PAIN 2 WK

4.02

100

2.674

.267

PAIN 8 WK

3.51

100

2.725

.272

Mean

Note: n=100

The multivariate mixed-effects analysis for the range of motion scores in degrees
and the self-reported pain scores, with comparisons of the marginal mean scores by
sample group at two and eight weeks, are shown in Table 3 and Figures 1, 2, and 3,
below. All three variables showed similar two- and eight-week scores for both sample
groups and comparisons of the changes in mean score by sample group indicated no
significant (p<0.05) difference between the intervention and control groups.
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Table 3
ON-Q Effects Over Time
Multivariate Tests
PFFAFF

Effect

Value

F

DF

DF

Sig

Err.

Partial

Noncent

Obs

Eta

Paramenter

Power

Squared
Pillai's Trace

.891

803.461ᵇ

1.00

98.0

.00

.891

803.461

1.00

Wilks'

.109

803.461ᵇ

1.00

98.0

.00

.891

803.461

1.00

8.199

803.461ᵇ

1.00

98.0

.000

.891

803.461

1.00

8.199

803.461ᵇ

1.00

98.0

.000

.891

803.461

1.00

Lambda
Hotelling's
Trace
Roy's Largest
Root
PFFAFF*

Pillai's Trace

.005

.473ᵇ

1.00

98.0

.493

.005

.473

.105

ON-Q

Wilks'

.995

.473ᵇ

1.00

98.0

.493

.005

.473

.105

.005

.473ᵇ

1.00

98.0

.493

.005

.473

.105

.005

.473ᵇ

1.00

98.0

.493

.005

.473

.105

Lambda
Wilks'
Lambda
Hotelling's
Trace
a. Design: Intercept + ONQ Within Subjects Design PFFAFF b. Exact Statistics c. Computed using alpha = .05
There was a non-significant difference between the groups in terms of how they changed across time for PFFAFF, p = 0.49
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Figure 1. Range of motion two- and eight-week marginal mean scores by sample group.

Figure 2. Range of motion two- and eight-week marginal mean scores by sample group.
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Figure 3. Self-reported pain two- and eight-week marginal mean scores by sample group.
As shown in Table 4, there were no significant (p<0.05) interaction effects
between the outcome variables, use of the ON-Q pain pump, or patient gender. Table 4
presents the marginal means and 95% confidence interval (CI) values of the range of
motion and pain score outcomes at both time points for the intervention (with ON-Q) and
control (without ON-Q) sample groups, as well as by gender.
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Table 4
Outcome Score Marginal Means, CIs, and p-values for Interactions by Sample Group
and Gender
Outcome

Group

Two Weeks

Eight Weeks

ON-Q (no)

101.9 (99.0 – 104.8)

157.6 (152.4 – 162.8)

ON-Q (yes)

104.7 (100.8 – 108.6)

163.2 (156.2 – 170.2)

Female

102.0 (98.5 – 105.6)

157.1 (150.7 – 163.4)

Male

103.6 (100.5 – 106.7)

161.6 (156.0 – 167.2)

ON-Q (no)

91.4 (89.1 – 93.7)

146.6 (139.7 – 153.4)

ON-Q (yes)

92.9 (89.8 – 96.0)

155.8 (146.7 – 165.0)

Female

91.7 (88.9 – 94.5)

146.6 (138.2 – 154.9)

Male

92.1 (89.7 –94.6)

152.5 (145.1 – 159.9)

ON-Q (no)

4.2 (3.5 – 4.8)

3.5 (2.8 – 4.2)

ON-Q (yes)

3.8 (2.9 – 4.6)

3.6 (2.7 – 4.5)

Female

4.4 (3.6 – 5.2)

4.3 (3.5 – 5.1)

Male

3.7 (3.0 – 4.4)

2.9 (2.2 – 3.6)

p-value

PFF/AFF

0.49

0.44

ABD

0.16

0.31

Pain

0.36

.013

Note: * All values are M (95% CI)

Summary
This chapter presented the outcomes of the data collection and analysis processes
in this project. Although the analytical results indicated that the sample had significantly
larger mean ranges of motion for both measures at eight weeks compared to two weeks,
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there was not a comparable significant reduction in pain scores. Moreover, no significant
changes in the range of motion or self-reported pain scores were observed when the
intervention and control group mean for these outcome variables were compared.
Likewise, the mixed-effects analyses indicated no significant (p<0.05) differences
between the control and intervention group marginal means for pain or range of motion
outcomes, nor interactions in changes over time for these outcomes, even when
controlling for participant gender. These results have implications for clinical practice
and future research, which are discussed in the final chapter, below.
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CHAPTER IV – DISCUSSION
Overview
The project results discussed in the previous chapter did not show that the ON-Q
pain pump and oral hydrocodone intervention condition was associated with significant
differences in pain or range of motion outcomes compared to the control condition of oral
hydrocodone-only. These results are discussed in more detail in this chapter. The first
section presents recommendations for future research. The second section details the
implications of the findings from this project for nursing practice in similar settings. The
third section identifies the limitations with this project. The dissemination plan for the
findings is presented afterward. The chapter ends with a conclusion summarizing the
points made in each section.
Recommendations
Based on the findings from the project, the ON-Q pain pump as an adjuvant
therapy with oral hydrocodone did not show pain relief or range of motion benefits for
arthroscopic shoulder surgery patients. This project's findings conflict with previous
research that found evidence for pain pumps as showing benefits as adjuvant therapies for
orthopedic surgery recovery, and those that indicated nerve blocks such as Marcaine and
ketorolac delivered by other methods of administration could reduce postoperative pain
for orthopedic shoulder surgery patients (Hamandi et al., 2013; Patacsil, 2016;
Srikumaran et al., 2013). These previous studies did not examine patients with secondary
chronic pain, so it may be necessary for future studies to compare whether patients with
secondary chronic pain do not respond as well to adjuvant therapies administered using
pain pumps compared to patients without chronic pain when both groups of patients are
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recovering from shoulder surgeries. Additionally, it may also be beneficial to study
whether other methods of administering Marcaine and ketorolac, outside of pain pumps,
could be associated with more substantial benefits for pain relief and range of motion
among shoulder surgery patients with chronic pain, or whether pain pumps containing
other adjuvant medications might be more beneficial.
The focus of this DNP project was to retrospectively review previously collected
organizational data to determine if postsurgical outcomes were improved with the
utilization of an ON-Q pain pump, in addition to the standard treatment for pain relief
involving the use of 7.5-10 mg hydrocodone when compared to the postsurgical
outcomes of patients who received only the standard of care for pain control following
orthopedic shoulder surgery. The organization collected data on both male and female
patients, between the ages of 40-64 years who underwent either a reverse total shoulder
arthroplasty or arthroscopic rotator cuff repair at the project setting between January 2017
and October 2018. The addition of an ON-Q pain pump following these procedures was
not determined by the project site but by the patient’s insurance carrier.
The scope of this DNP project was to determine if the improvement in patient
outcomes was significant enough to warrant the utilization of the ON-Q pain pump for
patients who had insurance carriers that did not cover this novel therapy; therefore, a
cost-minimization analysis was conducted. Utilization of the cost-minimization analysis
allows only the costs of an intervention to be evaluated without regard to the effect, as
this method operates under the assumption that the alternative treatment offers equivalent
outcomes (Frick, Cohen, & Stone, 2013). This cost-minimization analysis was utilized
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because the data analysis had already determined that there was no significant difference
between the measured outcomes of interest noted in either of the intervention groups.
The cost of the ON-Q pain pump is $300.00/unit. This cost includes the ON-Q
pain pump, the connecting catheter, and loading doses of both Marcaine and ketorolac (L.
Bauldin, personal communication, March 24, 2017). This price per unit would result in
$3,000.00 in cost for every 10 surgery patients who were covered under insurance
carriers that did not provide reimbursement for the ON-Q pain pump. The outcome
results for this DNP project were not significant enough to recommend the use of the
ON-Q pain pump for all patients regardless of insurance coverage.
Further collection and data review would be beneficial to perform a full economic
analysis, as there are multiple considerations that could be explored, not within the scope
of this DNP project. One concept for future exploration is savings of any downstream
costs. These downstream costs would include estimation of future beneficial savings
related to improved postsurgical outcomes including decreased utilization of
occupational/physical therapy and decreased incidence of future surgeries.
Implications for Future Practice
This project has possible implications for future practice. This project's findings
suggested that oral hydrocodone alone delivered similar postsurgical recovery benefits at
a lower cost when compared with oral hydrocodone and the ON-Q pain pump. Although
previous research, such as the study by Hamandi et al. (2013), indicated the combination
of opioid and adjuvant pain relief can benefit orthopedic shoulder surgery patients, this
project's findings did not agree. The findings in this study suggest that such a
combination might fail to produce benefits for orthopedic shoulder surgery patients who
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also have a history of secondary chronic pain in the same shoulder they have received
surgery on. Therefore, these findings suggest that adjuvant therapies lack sufficient
benefits for pain relief and range of motion recovery to recommend their use, especially
when the added costs to the patient and provider are considered. Until more evidence on
this practice issue is available, these findings imply that adjuvant therapies administered
using pain pump would not benefit this patient population.
Limitations
This project had some limitations. The sample was drawn from a single
geographic area and was a convenience sample of patients presenting at a single practice
setting. Therefore, the sample may not represent the population of orthopedic shoulder
surgery patients with secondary chronic shoulder pain, which creates limits on the
generalizability of these findings. Additionally, the project was a retrospective data
review and not a randomized controlled trial, so no conclusions regarding cause and
effect relationships between the ON-Q pain pump and the outcome measures can be
drawn.
Dissemination
The dissemination of this project's findings involves several steps. The data and
project findings were formatted and provided to the project leader's collaborating
physician, a certified board member, along with an executive summary (see Appendix E),
at the project site. The project leader along with the collaborating physician will present
the project findings to the board of directors at the project site, and the site's 17 partners,
at the next quarterly board meeting to determine whether the findings indicate that a
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change of practice at the project site's new surgical center should be developed based on
the available data review.
Conclusion
This project compared the use of the ON-Q pain pump, an adjuvant therapy with
Marcaine or Marcaine and ketorolac, as an adjuvant pain relief therapy administered with
oral hydrocodone, to hydrocodone alone, for patients with a history of secondary chronic
shoulder pain who received orthopedic shoulder surgery. The retrospective data review
involved range of motion and self-reported pain scores at two and eight weeks after
surgery indicated that the ON-Q pain pump plus hydrocodone condition was not
associated with significant benefits in pain relief or range of motion among adult patients
ages 40-64 compared to hydrocodone alone. These findings conflict with past research
outcomes, suggesting a need for more research on adjuvant pain relief therapies among
surgical patients who have a history of chronic pain. Despite the limitations of this
project, the findings indicated that the ON-Q pain pump may not deliver sufficient
benefits in practice for this patient population to recommend its use; however, future
exploration, including a more in-depth cost-benefit analysis may provide more
information to support adoption of the ON-Q pain pump as standard of care for
orthopedic shoulder surgery.
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APPENDIX A – Literature Matrix
Author/Year
Clarke, Nahin,
Barnes, &
Stussman
(2016)

Evanoff,
Sabbath,

Level
Design
Grade
Level 2 DescripGrade C tive
epidemiological
study
involving
a review of
retrospective
medical
histories

Sample/Data
Collection
34,525
American
adults,
representing a
79.7% response
rate from the
initial calls.
Data collection
involved
questionnaires
and reviews of
health records.

Level 2 Cohort
Grade B Study

9,415
participants, all
42

Findings

Limitation
s
The
survey
was
nationwide but
did not
represent
the entire
American
population
, and there
was a selfselection
bias in the
responses
making it
difficult to
say how
generalizable
the results
are to the
entire
American
population
.

Over half of
all people
interviewed
(54.5%) had
some type of
musculoskeletal pain
disorder
involving
chronic pain.
Significantly
more people
with
musculoskeletal pain
(41.6%)
used
adjuvant or
alternative
therapies
compared to
those
without such
pain
(24.1%), but
practitionerbased
approaches
(18.2%) and
systemic
medical
approaches
(5.3%) were
much less
common
than the use
of natural
products
(24.7%).
The results
The study
demonfocused

Carton,
Czernichow,
Zins, Leclerc,
& Descatha,
(2014

of whom were
retired males,
and between the
ages of 63-72
years of age at
the time of the
study. 2,762
were normal
weight (BMI
<24.9) 3,841
were
overweight
(BMI between
25-29.9, and
1,032 were
obese (BMI
>30). Data
collection
included
questionnaires
inquiring about
occupational
exposures to
various
activities such
as arm elevation
and squatting.
Shoulder and
knee pain were
also measured.
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strated that
long term
(>10 years)
of work
involving
arm
elevation as
well as
frequent
squatting
motions
were linked
to
significantly
higher risk
odds for
severe knee
and shoulder
pain (rated
as >5 on a 08 scale),
obesity was
found to be
a risk factor
(OR 1.28)
for severe
shoulder
pain, and
both obesity
(OR 1.71)
and
overweight
(OR 3.28)
significantly
increased
the risks for
severe knee
pain. BMI
was found to
mediate the
links
between
repetitive
squatting on
the job and

largely on
workingclass
males in
France
who had
spent
much of
their lives
doing
intensive
physical
activities.
These
results
may
generalize
to people
from other
cultures
with
similar
obesity
rates as
well as
similar
occupation
al
exposures
to heavy
lifting and
repeated
motion but
may not
necessarily
apply to
people
with
different
types of
career
paths.

Fanelli,
Cherubino, &
Compagnone
(2014

severe knee
pain after
the
participants
had entered
retirement.
Level 2 Descrip143 orthopaedic Even though
Grade C tive survey specialists from there had
study
Italy were
been a law
provided with
passed two
an online
years prior
survey. The
to the study
survey asked
making
about two basic opioid and
areas. First, it
non-opioid
inquired about
adjuvant
the level of
pain control
knowledge that medications
the orthopedic
more
specialists had
accessible to
regarding the
orthopedic
use of opioids
specialists,
and other forms only 101
of pain control
(70%)
such as adjuvant showed a
nerve blockers. high degree
Secondly, the
of being
survey inquired informed
about the actual about the
use, in terms of usage of
prescriptions,
these
that the
medications.
specialists
Moreover,
provided to
the majority,
their patients
54.5%, said
after their
that they did
surgeries.
not even
prescribe
opioids as a
remedy for
osteoarticular
pain rated as
severe,
largely due
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This study
was
conducted
among a
very
limited set
of
orthopedic
specialists
in a
European
nation that
sees far
lower
proportion
al usage of
opioid and
adjuvant
forms of
pain
control.
Cultural
and legal
differences,
plus the
small
sample
size, may
limit applicability
of the
results to
American
orthopedic
specialists.

Hamandi, AlKhafaji, & AlAtbee (2013)

Level 4

Case study
comparison
with a
small
sample
size

to concerns
over the side
effects of the
medications
and to a
lesser extent,
because of
patient
resistance to
their usage.
Five patients at All five
a single hospital patients
who had
received
undergone acute relief from a
surgery and
combination
who also had
of opioids
chronic pain.
postInfusion pump
surgically
usage was
and
measured
medication
through pain
to treat
ratings and
spasticity
spasticity.
and nerve
blocking,
resulting in
significant
decreases in
patientreported
pain, and
objectively
observed
spasticity as
measured by
physicians.
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The study
was
conducted
in the
nation of
Iraq,
where
pain
pumps are
relatively
new, and
therefore
their usage
in this
study
(combining the
opioid and
non-opioid
adjuvant
therapies
in pumps)
was
different
than the
protocol
that would
be
employed
by most
American
orthopedic
specialists,
where individuals

Jain, Higgins,
Level 2,
Losina, Collins, Grade C
Blazar, & Katz
(2014)

Descriptive
epidemiological
study
involving
a review of
retrospective

34.7 million
American
hospital visits
comprised from
52,233 records
gathered from
nationwide
hospitals and
ambulatory
46

would
receive
oral
opioids
along with
a pain
pump that
would be
capable of
delivering
the
adjuvant
therapy.
Additionally, the
study was
not solely
concerned
with
shoulder
surgeries
but dealt
with a
range of
chronic
pain and
orthopedic
issues.
Finally,
the sample
size of
five individuals
was
extremely
small.
272,148
This study
rotator cuff
was
surgeries
nationand 257,541 wide but
shoulder
does not
arthroscopy represent a
surgeries not complete
involving
view of
the rotator
orthopedic

medical
histories

Kim, Szabo, &
Marder (2012).

Level 2 DescripGrade C tive
epidemiological
study
involving
a review of
retrospective
medical
histories

surgery centers,
which showed
respective
response rates
of 75% and
74%. The data
collection
involved chart
reviews of the
types of
orthopedic
diagnoses and
procedures that
were used to
treat them.

28 million
emergency
department
records, which
included
hospitals and
ambulatory
surgery centers
nationwide.
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cuff had
been
performed in
2006 in the
United
States. The
rotator cuff
surgery was
the most
common in
65-74-yearolds (28.3
surgeries per
10,000
individuals)
followed by
55-64-yearolds.
Shoulder
arthroscopy
was usually
performed
due to
impingement
syndrome,
bursitis,
periarthritis,
and
instability.
There were
370,000
visits to
American
emergency
departments
in 2008 that
were related
to fractures
of the
humerus,
which can
require
orthopedic
surgery.

surgeries
for 2006
given that
the
response
rates were
not 100%
for all
locations
where
surgeries
were
performed
. Thus,
there
could be a
selfselection
bias in the
sample.

This study
was
nationwide but
does not
represent a
complete
view of
orthopedic
surgeries
for 2008
given that
the
response
rates were

Women 4080 years of
age
(R2=97.9%)
and men 6089 years of
age (R2 =
98.2%) were
at the
greatest risk
for these
issues.

Kim, Dutra, &
Okechukwu
(2014a)

Level 2 CrossGrade B Sectional
Study

1,772
construction
apprentices.
Safety practices
were evaluated
using a simple
questionnaire,
and injury
records were
used to evaluate
48

not 100%
for all
locations
where
surgeries
were
performed
. Thus,
there
could be a
selfselection
bias in the
sample
results.
Also,
humerus
fractures
can but do
not always
require
orthopedic
shoulder
surgery, so
these
figures
may not
accurately
represent
the
growing
need for
postsurgic
al therapy.
Fewer safety The
practices
sample
were linked representto higher
ed only a
and
single
significant
state's
odds of
coninjurystruction
related
workers
absences
and the
(OR 1.68).
question-

absences due to
injury.

Kim,
Okechukwu,
Dennerlein,
Boden, Hopcia,
Hashimoto, &
Sorensen
(2014b)

Level 2 CrossGrade B Sectional
Study

1,572 nurses
from two
teaching
hospitals.
Staffing was
measured
through the
Nursing Work
Index.
Musculoskeletal
pain was selfreported and
measured with
the Nordic
questionnaire.
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naire was
mostly
focused on
safety
making it
difficult to
draw conclusions
about
whether
the
injuries
led to
chronic
pain or
precipitated
surgical
needs.
The logistic The
regression
sample
model used
size was
revealed
large but
clustering
repwhere
resented
inadequate
only two
staffing
hospitals
showed a
that were
higher odds underratio for the staffed.
numbers of
Moreover,
body areas
underexperiencing staffing
chronic pain used a
(OR 1.5,
subjective
OR1.42
measure
respectively) making it
even after
more
taking into
difficult to
account job compare
duties,
objectivehaving a
ly undersecond job,
staffed
and the
and overnumber of
staffed

Matsen, Tang,
Russ, Hsu, &
Matsen (2017).

Level 3 A caseGrade B control
study
involving
range of
motion
tests

The sample
included 104
individuals with
osteoarthritis,
70 males and 30
females. The
data collection
involved
measuring the
range of motion
of patients
according to
subjective and
objective
measures. The
objective range
of motion
involved
measurements
with the Kinect
motion capture
system and the
subjective
measure
involved the
simple shoulder
test that is a
patient-based
measure of
shoulder
function.
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hours per
week.
Physical
work factors
influence
back pain,
but shoulder
pain
remained
significant
even when
this was
taken into
account.
The patients'
measurements of
shoulder
movement,
in particular
of active
abduction,
did not
correlate
well with
the objective
measures for
either males
(R2=0.25)
or females
(R2=0.29)
before the
surgery had
taken place.
Contralateral
shoulder
measures
were much
closer for
subjective
and
objective
measures for
males
(R2=0.46)

hospital
nurses in
terms of
pain.

The
patients
were
collected
from a
single
facility
and the
small
sample
size,
combined
with the
use of
only two
range of
motion
tests that
are not
used in all
studies on
this topic,
making
the results
possibly
not apply
to all
patients.

Measurements
were taken
before and after
surgery.

Narvy,
Ahluwalia, &
Vangsness
(2016)

Level 3 Case
Grade B Control
Study

and females
(R2=0.54).
Significant
differences
between
injured
shoulders
were found
between
active
abduction
and the
number of
shoulder
activities
completed
by
participants
for both men
and women,
and when
comparing
osteoarthritic and
contralateral
shoulders.
26 patients
The mean
requiring
operating
orthopedic
time was
surgery (28
148 minutes,
shoulders total). while 105
Costs were
minutes was
calculated based the mean
on operation
recovery
time, surgeries, time. The
and presurgeries
operative
averaged
information.
$5,904 in
cost.
Moreover,
the patients
had a mean
age of 54.5
years.
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Small
sample
size from
a single
location
which
may not
be
generalizable to
other
environments or
costing
sources.

Patacsil (2016)

Level 2 Systematic
Grade B review of
cohort
studies and
randomized
controlled
trials

29 articles,
including 3
review articles,
4 metaanalyses, and 22
RCTs. Data
collection
involved
comparison of
quantitative
results.
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Several pain
control
methods are
possible for
orthopedic
surgery, but
there are
problems
with using
partial
opioid
agonists, full
opioid
agonists,
and acetylcholine
inhibitors.
Adjuvant
inhibitors
seemed to be
more
effective
when
combined
with
standard
postoperative
opioid pain
management
for upper
extremity
surgeries as
compared to
lower
extremity
surgeries.
However,
there is a
need to
study
adjuvants
other than
dexamethasone

The main
limitations
included
the fact
that not all
adjuvant
inhibitors
have been
studied
thoroughly
, and
therefore
limited the
amount of
data that
the study
was able
to draw on
when
developing its
review.

Shin et al.,
(2016)

Level 3 CaseGrade B control
study with
pre and
post-test
measures

62 patients
comprising 63
shoulders that
received
revision
arthroscopic
anterior
shoulder
stabilization.
Data collection
was conducted
46.9+16.8
months later,
using several
measures
including the
simple shoulder
test, visual
analog pain
scale, shoulder
instability
index, and
American
Shoulder and
elbow surgeons
score.
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and
epinephrine
although
both seem to
be effective.
Also,
adjuvant
inhibitors
lower the
risks of
adverse
events due
to opioid
use.
The
significant
(p<0.001)
improvements
occurred in
the mean
simple
shoulder
test, visual
analog pain
scale, and
American
Shoulder
and elbow
surgeons
scores.
However,
there was
remaining
instability in
12 (19%)
shoulders,
which was
found to be
significantly
related to
having prior
shoulder
complications

Small
sample
size was
drawn
from a
single
clinic and
the use of
the simple
shoulder
test rather
than an
objective
test for
shoulder
movement
.

Srikumaran,
Stein, Tan,
Freehill, &
Wilckens
(2013)

Level 2 Systematic
Grade A review of
studies on
peripheral
nerve
blocks.

35 studies
including metaanalyses and
RCTs related to
upper extremity
peripheral nerve
blocks.

Tekavec et al,
(2012)

Level 2 DescripGrade C tive study
in a
population
comparing
shoulder
pain
prevalence
, pain
diagnoses,
and
medical
assistance

A single
country of
Sweden
containing a
total of
1,169,464
people of which
575,895 were
men, and
593,569 were
women. The
data was
collected from
54

resulting in
surgery as
well as
hyperlaxity.
Peripheral
nerve blocks
were found
to improve
the costeffectiveness
of
postsurgical
treatment,
reduce
perceived
pain on the
part of
patients, and
improve
range of
motion for
the patients.
They tended
to have low
rates of
adverse
effects and
complications.

Women
showed a
slightly
higher
consultation
prevalence
compared to
males, but
this was not
significant
(103 per
10,000
women

The sole
limitation
of this
study was
that it
would be
impacted
by any
limitations
of the
studies it
drew its
data from.
Also, the
study was
not solely
concerned
with
orthopedic
shoulder
surgery
nerve
blocks but
rather
those
involving
any upper
extremity.
Despite
the large
sample
size, the
study
collected
data from
only a
single
country of
Sweden,
where the
lifestyles,

seeking
patterns.

health care
register data
from public and
private
providers based
on ICD-10
coding of pain
and shoulder
diagnoses.

55

versus 98
per 10,000
men
annually).
Women also
showed
slightly
higher new
consultation
rates (80 per
10,000
women
versus 74
per 10,000
men
annually)
with the
respective
peak ages
for consultations
occurring at
ages 50-59
years for
women (129
per 10,000)
and 60-69
years for
men (116
per 10,000).
Twenty
percent of
people of
either sex
consulted
for three
months after
the
diagnosis,
but only a
few percent
past two
years from
the initial
diagnosis.

insurance
coverage,
barriers to
care, and
workforce
distribution,
as well as
age ranges
and BMI,
may be
very
different
from those
of the
United
States, so
caution
should be
used when
generalizing.

Vincent, Struk,
Reed, &
Wright (2016)

Consultations
were 1% for
shoulder
pain, with
rotator cuff
and
impingement
conditions
being the
most
frequent
acute
diagnoses.
Level 2 Cohort
310 individuals Morbidly
Grade B study
who had a total obese
comparing shoulder
individuals
two groups arthroplasty or
were more
of
reverse shoulder likely to
individuals arthroplasty,
have poorer
following
divided into
daily living
a total
groups of 167
functional
shoulder
non-obese
scores and
arthroindividuals
motion prior
plasty or
(BMI <25), 121 to surgery
reverse
obese
and reported
shoulder
individuals
a worse
(BMI between
quality of
30-39.9), and 22 life. After
morbidly obese surgery,
individuals
however, the
(BMI > 40).
main
Data was
significant
measured by
BMI effect
patient-reported was related
measures that
to external
included ASES rotation and
daily living
range of
assessments,
movement;
shoulder pain,
BMI was
and disability
significantly
index, shoulder and
rating scale,
negatively
radiological
correlated
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The study
used
several
patient
report
measures
which
may have
influenced
the
outcomes
somewhat.
However,
motion
ranges and
health
outcomes
were
measured
by
objective
sources
and thus
were not
limitations
. The
small
number of
morbidly
obese

outcomes,
chronic illness,
and adverse
events.
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with
movement,
as well as
reporting
worse
overall
health.

patients in
the study
may have
also
skewed
the results.

APPENDIX B – ON-Q Pharmacy Request Form
DATE: ___________ TIME: __________
DRUG ALLERGIES:
____________________________________________________________________or
 NKDA
PUMP
 CB004 Total Fill to 550 mL
FILL MEDICATION
 0.125% Marcaine
 0.125% Marcaine 400 mL plus 150 mL ketorolac
RATE
 Start flow at _____ mL per hour
 Adjust flow for increase pain by 2, not to exceed 10 mL per hour
DISCONTINUE
 ____________
 When ON-Q ball empty (hard yellow core)
 Patient home with pump, discharge instructions given.
 Catheter removal instructions are given.
CLINICAL INDICATION: The nature of surgery in this case will result in postsurgical
pain management that is non-routine and requires a continuous catheter for postoperative
pain control. Thus, I hereby refer the administration of a ON-Q pain ball.
____________________________________

_______________________

SURGEON SIGNATURE

DATE
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APPENDIX D – IRB Approval
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APPENDIX E – Executive Summary
Of the 19 million Americans who will undergo orthopedic shoulder surgery in the
next five years, 40% have two comorbid conditions affecting the same shoulder:
orthopedic pain and secondary chronic pain. Patients with these comorbid conditions
continue to experience post-surgical pain because orthopedic surgery does not address
secondary chronic pain, which affects their postsurgical recovery and increases costs of
care. Past studies of adjuvant pain relief therapies suggest that pain pumps dispensing
local anesthetics may relieve postsurgical chronic pain relief and facilitate improved
healing, but these studies did not specifically examine postsurgical comorbid orthopedic
pain and secondary chronic pain for shoulder surgery patients or measure the range of
motion as an outcome. This project accordingly investigated whether, for adult
orthopedic shoulder surgery patients 40-64 years old who had a ≥3 month diagnostic
history of secondary chronic shoulder pain, postsurgical pain relief with an ON-Q pain
pump and oral hydrocodone, versus standard pain relief with oral hydrocodone alone,
increased range of shoulder motion and reduced pain on a 10 point Likert scale at 2 and 8
weeks after surgery. A quantitative retrospective data analysis of patient health records
was conducted for 100 men and women who received total shoulder arthroplasty or
arthroscopic rotator cuff tear repair at a single clinic between January 2017 and October
2018. The findings indicated that the ON-Q pain pump with oral hydrocodone did not
significantly improve pain relief or range of motion outcomes compared to oral
hydrocodone alone. These findings have implications for practice and future research.
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